Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1sr7 | MOF | Progesterone receptor |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
1sr7 | MOF | Progesterone receptor | / | 1.000 | |
4p6w | MOF | Glucocorticoid receptor | / | 0.579 | |
1sqn | NDR | Progesterone receptor | / | 0.573 | |
1p93 | DEX | Glucocorticoid receptor | / | 0.554 | |
2w8y | 486 | Progesterone receptor | / | 0.542 | |
3zrb | ORC | Progesterone receptor | / | 0.538 | |
2w8y | NDR | Progesterone receptor | / | 0.531 | |
4a2j | AS0 | Progesterone receptor | / | 0.530 | |
4uda | DEX | Mineralocorticoid receptor | / | 0.528 | |
2ovm | AS0 | Progesterone receptor | / | 0.522 | |
3d90 | NOG | Progesterone receptor | / | 0.520 | |
2oax | SNL | Mineralocorticoid receptor | / | 0.517 | |
4apu | A2K | Progesterone receptor | / | 0.514 | |
3zrb | OR8 | Progesterone receptor | / | 0.513 | |
4apu | OR8 | Progesterone receptor | / | 0.510 | |
2ab2 | SNL | Mineralocorticoid receptor | / | 0.505 | |
1zuc | T98 | Progesterone receptor | / | 0.503 | |
3zr7 | OR8 | Progesterone receptor | / | 0.501 | |
4p6x | HCY | Glucocorticoid receptor | / | 0.501 | |
2a3i | C0R | Mineralocorticoid receptor | / | 0.500 | |
4udc | DEX | Glucocorticoid receptor | / | 0.499 | |
2aax | PDN | Mineralocorticoid receptor | / | 0.498 | |
4lsj | LSJ | Glucocorticoid receptor | / | 0.497 | |
1ya3 | STR | Mineralocorticoid receptor | / | 0.494 | |
1e3k | R18 | Progesterone receptor | / | 0.492 | |
4y8w | STR | Steroid 21-hydroxylase | / | 0.492 | |
2aa2 | AS4 | Mineralocorticoid receptor | / | 0.489 | |
2aa5 | STR | Mineralocorticoid receptor | / | 0.489 | |
2aa6 | STR | Mineralocorticoid receptor | / | 0.488 | |
3zra | ORB | Progesterone receptor | / | 0.487 | |
1gs4 | ZK5 | Androgen receptor | / | 0.486 | |
1m2z | DEX | Glucocorticoid receptor | / | 0.486 | |
5akk | 1P8 | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.483 | |
3l6j | Z90 | Alr2278 protein | / | 0.482 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.480 | |
3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.480 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.480 | |
2abi | 1CA | Mineralocorticoid receptor | / | 0.479 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.476 | |
3vhu | SNL | Mineralocorticoid receptor | / | 0.476 | |
1x8l | OXR | Retinol dehydratase | / | 0.473 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.472 | |
2ylp | TES | Androgen receptor | / | 0.471 | |
4q0a | 4OA | Vitamin D3 receptor A | / | 0.471 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.469 | |
4o71 | CPB | Bromodomain-containing protein 4 | / | 0.469 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.468 | |
4oea | DHT | Androgen receptor | / | 0.468 | |
2pix | DHT | Androgen receptor | / | 0.467 | |
2q7i | TES | Androgen receptor | / | 0.467 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.467 | |
4i2q | 1BT | Gag-Pol polyprotein | 2.7.7.49 | 0.467 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.466 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.466 | |
1osv | CHC | Bile acid receptor | / | 0.465 | |
2ylq | TES | Androgen receptor | / | 0.464 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.464 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.463 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.463 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.461 | |
2zlc | VDX | Vitamin D3 receptor | / | 0.461 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.461 | |
3of2 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.461 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.461 | |
3zqt | TES | Androgen receptor | / | 0.461 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.461 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.460 | |
1xiu | REA | Retinoic acid receptor RXR | / | 0.460 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
1fml | RTL | Retinol dehydratase | / | 0.459 | |
1kzj | CB3 | Thymidylate synthase | / | 0.459 | |
2pkl | DHT | Androgen receptor | / | 0.459 | |
2q7k | TES | Androgen receptor | / | 0.459 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.459 | |
2p15 | EZT | Estrogen receptor | / | 0.458 | |
2pir | DHT | Androgen receptor | / | 0.458 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.458 | |
4iae | 1DX | Alr2278 protein | / | 0.458 | |
1fm6 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.457 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.457 | |
2has | C3O | Vitamin D3 receptor | / | 0.457 | |
3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.457 | |
4uyg | 73B | Bromodomain-containing protein 2 | / | 0.457 | |
1fmj | RTL | Retinol dehydratase | / | 0.456 | |
1og5 | SWF | Cytochrome P450 2C9 | / | 0.456 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.456 | |
1nhz | 486 | Glucocorticoid receptor | / | 0.455 | |
1s9q | OHT | Estrogen-related receptor gamma | / | 0.455 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.455 | |
4ivy | 1GT | Estrogen receptor | / | 0.455 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.455 | |
1l2j | ETC | Estrogen receptor beta | / | 0.454 | |
3vt6 | 5YI | Vitamin D3 receptor | / | 0.454 | |
4f4d | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.454 | |
1s19 | MC9 | Vitamin D3 receptor | / | 0.453 | |
1xdd | AAY | Integrin alpha-L | / | 0.453 | |
2ama | DHT | Androgen receptor | / | 0.453 | |
2amb | 17H | Androgen receptor | / | 0.453 | |
3vru | YS3 | Vitamin D3 receptor | / | 0.453 | |
4jqh | 1MF | Alr2278 protein | / | 0.453 | |
1ddu | CB3 | Thymidylate synthase | / | 0.452 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.452 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.452 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
3vtb | TKA | Vitamin D3 receptor | / | 0.452 | |
5b1y | NDP | 3-oxoacyl-[acyl-carrier-protein] reductase | / | 0.452 | |
1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
1m79 | MQ1 | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.451 | |
2acl | REA | Retinoic acid receptor RXR-alpha | / | 0.451 | |
2bj4 | OHT | Estrogen receptor | / | 0.451 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.451 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.451 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.451 | |
4nie | NBH | Nuclear receptor ROR-gamma | / | 0.451 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.451 | |
1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.450 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
2aqk | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.450 | |
3mne | DEX | Glucocorticoid receptor | / | 0.450 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.450 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.450 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.450 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.450 | |
4oxy | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.449 | |
2aa7 | 1CA | Mineralocorticoid receptor | / | 0.449 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.449 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.449 | |
3tdl | 11D | Serum albumin | / | 0.449 | |
3vtc | TK3 | Vitamin D3 receptor | / | 0.449 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.449 | |
4isk | 1JY | Thymidylate synthase | / | 0.449 | |
4iv4 | 1GS | Estrogen receptor | / | 0.449 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.449 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.448 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
1t65 | DHT | Androgen receptor | / | 0.448 | |
1t7r | DHT | Androgen receptor | / | 0.448 | |
2ao6 | R18 | Androgen receptor | / | 0.448 | |
2har | OCC | Vitamin D3 receptor | / | 0.448 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.448 | |
2vf0 | F89 | Thymidylate synthase | / | 0.448 | |
3vrv | YSD | Vitamin D3 receptor | / | 0.448 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.447 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.447 | |
1t79 | DHT | Androgen receptor | / | 0.447 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.447 | |
2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.447 | |
2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.447 | |
3ozd | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.447 | |
1al8 | DHP | Peroxisomal (S)-2-hydroxy-acid oxidase | 1.1.3.15 | 0.446 | |
2hc4 | VDX | Vitamin D3 receptor A | / | 0.446 | |
3mno | DEX | Glucocorticoid receptor | / | 0.446 | |
3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.446 | |
4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.446 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.446 | |
5doz | NDP | JamJ | / | 0.446 | |
1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.445 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.445 | |
2zl9 | VDA | Vitamin D3 receptor | / | 0.445 | |
3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.445 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4k7a | DHT | Androgen receptor | / | 0.445 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.445 | |
1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.444 | |
1t7f | DHT | Androgen receptor | / | 0.444 | |
2ham | C33 | Vitamin D3 receptor | / | 0.444 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.444 | |
2yhd | TES | Androgen receptor | / | 0.444 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.444 | |
3irx | UDR | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.444 | |
3up0 | D7S | aceDAF-12 | / | 0.444 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.444 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.444 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.444 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.444 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.443 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.443 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.443 | |
2ath | 3EA | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2bw7 | ECS | Adenylate cyclase | / | 0.443 | |
2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
2q8s | L92 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.443 | |
3ijd | C2F | Methylenetetrahydrofolate reductase | / | 0.443 | |
3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.443 | |
5l7d | CLR | Smoothened homolog | / | 0.443 | |
1b4v | FAD | Cholesterol oxidase | 1.1.3.6 | 0.442 | |
1nde | MON | Estrogen receptor beta | / | 0.442 | |
1y9r | 1CA | Mineralocorticoid receptor | / | 0.442 | |
2aq8 | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
2piu | DHT | Androgen receptor | / | 0.442 | |
2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.442 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.442 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.442 | |
4nm9 | FAD | Bifunctional protein PutA | / | 0.442 | |
4oha | HFT | Androgen receptor | / | 0.442 | |
1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
1mxt | FAE | Cholesterol oxidase | 1.1.3.6 | 0.441 | |
1rdt | L79 | Retinoic acid receptor RXR-alpha | / | 0.441 | |
2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
2pio | DHT | Androgen receptor | / | 0.441 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.441 | |
3p9t | TCL | Repressor | / | 0.441 | |
3t14 | FAD | Sulfide-quinone reductase | / | 0.441 | |
4bqp | VMY | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
1ot7 | CHC | Bile acid receptor | / | 0.440 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.440 | |
2yne | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.440 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.440 | |
4iw8 | KN3 | Estrogen receptor | / | 0.440 | |
4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.440 |